Otsuka Pharmaceutical: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 28: | Line 28: | ||
[[Category:Japanese brands]] | [[Category:Japanese brands]] | ||
{{pharmacology-stub}} | {{pharmacology-stub}} | ||
``` | |||
== Otsuka Pharmaceutical == | |||
<gallery> | |||
File:Products_of_Otsuka_Pharmaceutical.jpg | |||
</gallery> | |||
Latest revision as of 22:12, 16 February 2025
Otsuka Pharmaceutical Co., Ltd. (Japanese: 大塚製薬株式会社, Otsuka Seiyaku Kabushiki-gaisha), is a global pharmaceutical and nutraceutical company founded in 1964. It is headquartered in Tokyo, Japan. The company is a subsidiary of Otsuka Holdings Co., Ltd..
History[edit]
Otsuka Pharmaceutical was established in Japan in 1964. The company started as a manufacturer of intravenous solutions and expanded its business to pharmaceuticals, nutraceuticals, and other healthcare products.
Products[edit]
Otsuka Pharmaceutical is known for its flagship product, Abilify (aripiprazole), an antipsychotic medication used in the treatment of schizophrenia and bipolar disorder. Other notable products include Pocari Sweat, a popular sports drink, and Nature Made vitamins.
Research and Development[edit]
Otsuka Pharmaceutical is committed to the research and development of innovative products that address unmet medical needs. The company's research areas include neuroscience, oncology, cardiology, and gastroenterology.
Global Presence[edit]
Otsuka Pharmaceutical operates globally with subsidiaries in various countries including the United States, Canada, Europe, Asia, and Australia.
See Also[edit]
References[edit]
<references />
External Links[edit]
```
